Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies

OBJECTIVE: To analyze the efficacy and safety of paliperidone palmitate 3-monthly (PP3M) in Latin American patients with schizophrenia vs. rest-of-world (ROW). METHODS: We analyzed data from two multinational, double-blind (DB), randomized, controlled phase 3 studies including patients with schizoph...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Braz J Psychiatry
Main Authors: Savitz, Adam J., Xu, Haiyan, Gopal, Srihari, Nuamah, Isaac, Mathews, Maju, Soares, Bernardo
Formato: Artigo
Idioma:Inglês
Publicado: Associação Brasileira de Psiquiatria 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899357/
https://ncbi.nlm.nih.gov/pubmed/30994855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1516-4446-2018-0153
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares